NCT02264769View on ClinicalTrials.gov

Carbetocin at Elective Cesarean Delivery Part 4

NACompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

May 31, 2015

Conditions
Postpartum Hemorrhage
Interventions
DRUG

Carbetocin

Trial Locations (1)

M5G1X5

Mount Sinai Hospital, Toronto

All Listed Sponsors
lead

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

OTHER

NCT02264769 - Carbetocin at Elective Cesarean Delivery Part 4 | Biotech Hunter | Biotech Hunter